Who owns SPDR S&P Pharmaceuticals?
- Ticker: XPH
- CUSIP Number: 78464A722
Tip: Access positions for across all investors
Analyze quarterly positions in SPDR S&P Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of SPDR S&P Pharmaceuticals stock
Who bought or sold SPDR S&P Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 496k | $20M | 100% | Jun 2025 |
|
| Envestnet Asset Management | 224k | $11M | 100% | Sep 2025 |
|
| LPL Financial | 183k | $8.8M | 64% | Sep 2025 |
|
| First Citizens Bank & Trust | 181k | $8.7M | 3% | Sep 2025 |
|
| Envestnet Portfolio Solutions | 172k | $8.2M | 7% | Sep 2025 |
|
| Goldman Sachs Group | 111k | $5.3M | -7% | Sep 2025 |
|
| Susquehanna International | 93k | $4.5M | -20% | Sep 2025 |
|
| Wells Fargo & Company | 75k | $3.6M | 4% | Sep 2025 |
|
| Cetera Investment Advisers | 69k | $3.3M | 952% | Sep 2025 |
|
| Jpmorgan Chase & Co | 59k | $2.8M | 12% | Sep 2025 |
|
| CX Institutional | 51k | $2.5M | 20659% | Sep 2025 |
|
| Wharton Business Group | 51k | $2.4M | -4% | Sep 2025 |
|
| Clark Capital Management Group | 47k | $2.2M | 100% | Sep 2025 |
|
| Bp Wealth Management | 42k | $2.0M | 2% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 40k | $1.9M | 0% | Sep 2025 |
|
| UBS Group | 36k | $1.7M | 16% | Sep 2025 |
|
| MAI Wealth Advisors | 30k | $1.5M | -16% | Sep 2025 |
|
| Gts Securities | 28k | $1.3M | 47% | Sep 2025 |
|
| Royal Bank of Canada | 27k | $1.3M | 0% | Sep 2025 |
|
| Mml Investors Services | 26k | $1.2M | 100% | Sep 2025 |
|
| Rockefeller Capital Management | 19k | $931k | -5% | Sep 2025 |
|
| Pnc Financial Services | 18k | $883k | -2% | Sep 2025 |
|
| Raymond James Financial | 16k | $783k | 26% | Sep 2025 |
|
| U.S. Capital Wealth Advisors | 15k | $706k | 3% | Sep 2025 |
|
| Advisor Group Holdings | 14k | $665k | 185% | Sep 2025 |
|
| NewEdge Wealth | 11k | $539k | -7% | Sep 2025 |
|
| Park Avenue Securities | 10k | $485k | 100% | Sep 2025 |
|
| Concurrent Investment Advisors | 8.1k | $388k | 0% | Sep 2025 |
|
| EP Wealth Advisors | 6.8k | $278k | 100% | Jun 2025 |
|
| Fragasso | 6.7k | $327k | 0% | Sep 2025 |
|
| Sigma Planning | 5.8k | $280k | 1% | Sep 2025 |
|
| Citadel Advisors | 5.7k | $275k | -85% | Sep 2025 |
|
| Baird Financial | 5.3k | $253k | 0% | Sep 2025 |
|
| Principal Securities | 5.2k | $250k | 1754% | Sep 2025 |
|
| Branch Banking & Trust Company | 5.1k | $243k | -2% | Sep 2025 |
|
| Evelyn Partners Investment Management | 4.6k | $222k | -6% | Sep 2025 |
|
| Janney Montgomery Scott | 4.4k | $209k | 100% | Sep 2025 |
|
| Advantage Trust | 3.3k | $156k | 0% | Sep 2025 |
|
| FMR | 2.8k | $135k | -13% | Sep 2025 |
|
| Atlantic Trust | 2.8k | $135k | 1% | Sep 2025 |
|
| National Bank Of Canada /fi/ | 2.5k | $118k | 2% | Sep 2025 |
|
| Bank Of Montreal | 2.4k | $97k | 100% | Jun 2025 |
|
| Nbc Securities | 1.8k | $85k | -18% | Sep 2025 |
|
| Jones Financial Companies, L.L | 1.3k | $63k | -8% | Sep 2025 |
|
| William Blair $ Company | 851.00 | $41k | 0% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 821.00 | $39k | 15% | Sep 2025 |
|
| Hanson McClain Advisors | 790.00 | $38k | 0% | Sep 2025 |
|
| Advisory Services Network | 700.00 | $34k | 100% | Sep 2025 |
|
| Whittier Trust | 650.00 | $32k | 0% | Sep 2025 |
|
| Brian McDonald | 594.00 | $29k | 32% | Sep 2025 |
|
| AE Wealth Management | 452.00 | $22k | 0% | Sep 2025 |
|
| Sontag Advisory | 402.00 | $19k | 100% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $19k | 0% | Sep 2025 |
|
| Alerus Financial | 375.00 | $18k | 0% | Sep 2025 |
|
| Goss Wealth Management | 260.00 | $13k | 2500% | Sep 2025 |
|
| CWM | 200.00 | $10k | 0% | Sep 2025 |
|
| Addison Advisors | 188.00 | $9.0k | 0% | Sep 2025 |
|
| Steward Partners Investment Advisory | 179.00 | $8.6k | 100% | Sep 2025 |
|
| Ronald Blue Trust | 145.00 | $7.0k | 100% | Sep 2025 |
|
| Global Retirement Partners | 113.00 | $5.4k | -8% | Sep 2025 |
|
| O'shaughnessy Asset Management | 65.00 | $3.1k | 100% | Sep 2025 |
|
| CoreCap Advisors | 41.00 | $2.0k | 0% | Sep 2025 |
|
| Jackson Hole Capital Partners | 35.00 | $1.7k | 100% | Sep 2025 |
|
| Front Row Advisors | 18.00 | $867.000600 | -33% | Sep 2025 |
|
| Tower Research Capital | 2.00 | $96.000000 | -67% | Sep 2025 |
|
| Qube Research & Technologies | 2.00 | $96.000000 | 0% | Sep 2025 |
|
| Huntington National Bank | 1.00 | $48.000000 | 0% | Sep 2025 |
|
Who sold out of SPDR S&P Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Kingsview Wealth Management | Jun 2025 | 237k | $9.6M |
| Ameritas Advisory Services | Jun 2025 | 9.6k | $389k |
| Captrust Financial Advisors | Jun 2025 | 5.3k | $216k |
| Rockport Wealth | Jun 2025 | 5.0k | $203k |
| Us Bancorp | Jun 2025 | 2.2k | $90k |
| NorthRock Partners | Mar 2025 | 1.5k | $67k |
| Barclays | Jun 2025 | 1.5k | $61k |
| Brown Brothers Harriman & Co. | Jun 2025 | 948.00 | $39k |